The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hospital-acquired Urinary Tract Infection Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2028

Global Hospital-acquired Urinary Tract Infection Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2028

Publishing Date : Feb, 2022

License Type :
 

Report Code : 1637054

No of Pages : 104

Ask Your Query
Synopsis
The Hospital-acquired Urinary Tract Infection Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hospital-acquired Urinary Tract Infection Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals and outpatient department accounting for % of the Hospital-acquired Urinary Tract Infection Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Assay kits and consumables segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Hospital-acquired Urinary Tract Infection Testing include bioMérieux, Roche Diagnostics, Siemens Healthineer, ACON Laboratories, and Abbott, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hospital-acquired Urinary Tract Infection Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Assay kits and consumables
Instruments
Market segment by Application, can be divided into
Hospitals and outpatient department
Diagnostics clinical laboratories
Market segment by players, this report covers
bioMérieux
Roche Diagnostics
Siemens Healthineer
ACON Laboratories
Abbott
ARKRAY
Beckman Coulter
Becton Dickinson
Bio-Rad
Cepheid
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Hospital-acquired Urinary Tract Infection Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hospital-acquired Urinary Tract Infection Testing, with revenue, gross margin and global market share of Hospital-acquired Urinary Tract Infection Testing from 2019 to 2022.
Chapter 3, the Hospital-acquired Urinary Tract Infection Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Hospital-acquired Urinary Tract Infection Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Hospital-acquired Urinary Tract Infection Testing research findings and conclusion, appendix and data source.

Geographical Area
Global
Index
1 Market Overview
1.1 Product Overview and Scope of Hospital-acquired Urinary Tract Infection Testing
1.2 Classification of Hospital-acquired Urinary Tract Infection Testing by Type
1.2.1 Overview: Global Hospital-acquired Urinary Tract Infection Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Type in 2021
1.2.3 Assay kits and consumables
1.2.4 Instruments
1.3 Global Hospital-acquired Urinary Tract Infection Testing Market by Application
1.3.1 Overview: Global Hospital-acquired Urinary Tract Infection Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and outpatient department
1.3.3 Diagnostics clinical laboratories
1.4 Global Hospital-acquired Urinary Tract Infection Testing Market Size & Forecast
1.5 Global Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast by Region
1.5.1 Global Hospital-acquired Urinary Tract Infection Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Hospital-acquired Urinary Tract Infection Testing Market Size by Region, (2017-2022)
1.5.3 North America Hospital-acquired Urinary Tract Infection Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Hospital-acquired Urinary Tract Infection Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Size and Prospect (2017-2028)
1.5.6 South America Hospital-acquired Urinary Tract Infection Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Hospital-acquired Urinary Tract Infection Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hospital-acquired Urinary Tract Infection Testing Market Drivers
1.6.2 Hospital-acquired Urinary Tract Infection Testing Market Restraints
1.6.3 Hospital-acquired Urinary Tract Infection Testing Trends Analysis
2 Company Profiles
2.1 bioMérieux
2.1.1 bioMérieux Details
2.1.2 bioMérieux Major Business
2.1.3 bioMérieux Hospital-acquired Urinary Tract Infection Testing Product and Solutions
2.1.4 bioMérieux Hospital-acquired Urinary Tract Infection Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 bioMérieux Recent Developments and Future Plans
2.2 Roche Diagnostics
2.2.1 Roche Diagnostics Details
2.2.2 Roche Diagnostics Major Business
2.2.3 Roche Diagnostics Hospital-acquired Urinary Tract Infection Testing Product and Solutions
2.2.4 Roche Diagnostics Hospital-acquired Urinary Tract Infection Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Roche Diagnostics Recent Developments and Future Plans
2.3 Siemens Healthineer
2.3.1 Siemens Healthineer Details
2.3.2 Siemens Healthineer Major Business
2.3.3 Siemens Healthineer Hospital-acquired Urinary Tract Infection Testing Product and Solutions
2.3.4 Siemens Healthineer Hospital-acquired Urinary Tract Infection Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Siemens Healthineer Recent Developments and Future Plans
2.4 ACON Laboratories
2.4.1 ACON Laboratories Details
2.4.2 ACON Laboratories Major Business
2.4.3 ACON Laboratories Hospital-acquired Urinary Tract Infection Testing Product and Solutions
2.4.4 ACON Laboratories Hospital-acquired Urinary Tract Infection Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 ACON Laboratories Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Hospital-acquired Urinary Tract Infection Testing Product and Solutions
2.5.4 Abbott Hospital-acquired Urinary Tract Infection Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Abbott Recent Developments and Future Plans
2.6 ARKRAY
2.6.1 ARKRAY Details
2.6.2 ARKRAY Major Business
2.6.3 ARKRAY Hospital-acquired Urinary Tract Infection Testing Product and Solutions
2.6.4 ARKRAY Hospital-acquired Urinary Tract Infection Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 ARKRAY Recent Developments and Future Plans
2.7 Beckman Coulter
2.7.1 Beckman Coulter Details
2.7.2 Beckman Coulter Major Business
2.7.3 Beckman Coulter Hospital-acquired Urinary Tract Infection Testing Product and Solutions
2.7.4 Beckman Coulter Hospital-acquired Urinary Tract Infection Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Beckman Coulter Recent Developments and Future Plans
2.8 Becton Dickinson
2.8.1 Becton Dickinson Details
2.8.2 Becton Dickinson Major Business
2.8.3 Becton Dickinson Hospital-acquired Urinary Tract Infection Testing Product and Solutions
2.8.4 Becton Dickinson Hospital-acquired Urinary Tract Infection Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Becton Dickinson Recent Developments and Future Plans
2.9 Bio-Rad
2.9.1 Bio-Rad Details
2.9.2 Bio-Rad Major Business
2.9.3 Bio-Rad Hospital-acquired Urinary Tract Infection Testing Product and Solutions
2.9.4 Bio-Rad Hospital-acquired Urinary Tract Infection Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Bio-Rad Recent Developments and Future Plans
2.10 Cepheid
2.10.1 Cepheid Details
2.10.2 Cepheid Major Business
2.10.3 Cepheid Hospital-acquired Urinary Tract Infection Testing Product and Solutions
2.10.4 Cepheid Hospital-acquired Urinary Tract Infection Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Cepheid Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hospital-acquired Urinary Tract Infection Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Hospital-acquired Urinary Tract Infection Testing Players Market Share in 2021
3.2.2 Top 10 Hospital-acquired Urinary Tract Infection Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Hospital-acquired Urinary Tract Infection Testing Players Head Office, Products and Services Provided
3.4 Hospital-acquired Urinary Tract Infection Testing Mergers & Acquisitions
3.5 Hospital-acquired Urinary Tract Infection Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Hospital-acquired Urinary Tract Infection Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Hospital-acquired Urinary Tract Infection Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Application (2017-2022)
5.2 Global Hospital-acquired Urinary Tract Infection Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2017-2028)
6.2 North America Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2028)
6.3 North America Hospital-acquired Urinary Tract Infection Testing Market Size by Country
6.3.1 North America Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2017-2028)
6.3.2 United States Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2017-2028)
7.2 Europe Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2028)
7.3 Europe Hospital-acquired Urinary Tract Infection Testing Market Size by Country
7.3.1 Europe Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2017-2028)
7.3.2 Germany Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
7.3.3 France Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Market Size by Region
8.3.1 Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue by Region (2017-2028)
8.3.2 China Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
8.3.5 India Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2017-2028)
9.2 South America Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2028)
9.3 South America Hospital-acquired Urinary Tract Infection Testing Market Size by Country
9.3.1 South America Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2017-2028)
9.3.2 Brazil Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Market Size by Country
10.3.1 Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2017-2028)
10.3.2 Turkey Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Hospital-acquired Urinary Tract Infection Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Hospital-acquired Urinary Tract Infection Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Hospital-acquired Urinary Tract Infection Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Hospital-acquired Urinary Tract Infection Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Region (2023-2028)
Table 6. bioMérieux Corporate Information, Head Office, and Major Competitors
Table 7. bioMérieux Major Business
Table 8. bioMérieux Hospital-acquired Urinary Tract Infection Testing Product and Solutions
Table 9. bioMérieux Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 11. Roche Diagnostics Major Business
Table 12. Roche Diagnostics Hospital-acquired Urinary Tract Infection Testing Product and Solutions
Table 13. Roche Diagnostics Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Siemens Healthineer Corporate Information, Head Office, and Major Competitors
Table 15. Siemens Healthineer Major Business
Table 16. Siemens Healthineer Hospital-acquired Urinary Tract Infection Testing Product and Solutions
Table 17. Siemens Healthineer Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. ACON Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. ACON Laboratories Major Business
Table 20. ACON Laboratories Hospital-acquired Urinary Tract Infection Testing Product and Solutions
Table 21. ACON Laboratories Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Abbott Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Major Business
Table 24. Abbott Hospital-acquired Urinary Tract Infection Testing Product and Solutions
Table 25. Abbott Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. ARKRAY Corporate Information, Head Office, and Major Competitors
Table 27. ARKRAY Major Business
Table 28. ARKRAY Hospital-acquired Urinary Tract Infection Testing Product and Solutions
Table 29. ARKRAY Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 31. Beckman Coulter Major Business
Table 32. Beckman Coulter Hospital-acquired Urinary Tract Infection Testing Product and Solutions
Table 33. Beckman Coulter Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Becton Dickinson Corporate Information, Head Office, and Major Competitors
Table 35. Becton Dickinson Major Business
Table 36. Becton Dickinson Hospital-acquired Urinary Tract Infection Testing Product and Solutions
Table 37. Becton Dickinson Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 39. Bio-Rad Major Business
Table 40. Bio-Rad Hospital-acquired Urinary Tract Infection Testing Product and Solutions
Table 41. Bio-Rad Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Cepheid Corporate Information, Head Office, and Major Competitors
Table 43. Cepheid Major Business
Table 44. Cepheid Hospital-acquired Urinary Tract Infection Testing Product and Solutions
Table 45. Cepheid Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Hospital-acquired Urinary Tract Infection Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Hospital-acquired Urinary Tract Infection Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Hospital-acquired Urinary Tract Infection Testing Players Head Office, Products and Services Provided
Table 50. Hospital-acquired Urinary Tract Infection Testing Mergers & Acquisitions in the Past Five Years
Table 51. Hospital-acquired Urinary Tract Infection Testing New Entrants and Expansion Plans
Table 52. Global Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million) by Type (2017-2022)
Table 53. Global Hospital-acquired Urinary Tract Infection Testing Revenue Share by Type (2017-2022)
Table 54. Global Hospital-acquired Urinary Tract Infection Testing Revenue Forecast by Type (2023-2028)
Table 55. Global Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2022)
Table 56. Global Hospital-acquired Urinary Tract Infection Testing Revenue Forecast by Application (2023-2028)
Table 57. North America Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Hospital-acquired Urinary Tract Infection Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Hospital-acquired Urinary Tract Infection Testing Picture
Figure 2. Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Type in 2021
Figure 3. Assay kits and consumables
Figure 4. Instruments
Figure 5. Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Application in 2021
Figure 6. Hospitals and outpatient department Picture
Figure 7. Diagnostics clinical laboratories Picture
Figure 8. Global Hospital-acquired Urinary Tract Infection Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Hospital-acquired Urinary Tract Infection Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Region (2017-2028)
Figure 11. Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Region in 2021
Figure 12. North America Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Hospital-acquired Urinary Tract Infection Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Hospital-acquired Urinary Tract Infection Testing Market Drivers
Figure 18. Hospital-acquired Urinary Tract Infection Testing Market Restraints
Figure 19. Hospital-acquired Urinary Tract Infection Testing Market Trends
Figure 20. bioMérieux Recent Developments and Future Plans
Figure 21. Roche Diagnostics Recent Developments and Future Plans
Figure 22. Siemens Healthineer Recent Developments and Future Plans
Figure 23. ACON Laboratories Recent Developments and Future Plans
Figure 24. Abbott Recent Developments and Future Plans
Figure 25. ARKRAY Recent Developments and Future Plans
Figure 26. Beckman Coulter Recent Developments and Future Plans
Figure 27. Becton Dickinson Recent Developments and Future Plans
Figure 28. Bio-Rad Recent Developments and Future Plans
Figure 29. Cepheid Recent Developments and Future Plans
Figure 30. Global Hospital-acquired Urinary Tract Infection Testing Revenue Share by Players in 2021
Figure 31. Hospital-acquired Urinary Tract Infection Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Hospital-acquired Urinary Tract Infection Testing Revenue Market Share in 2021
Figure 33. Global Top 10 Players Hospital-acquired Urinary Tract Infection Testing Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Hospital-acquired Urinary Tract Infection Testing Revenue Share by Type in 2021
Figure 36. Global Hospital-acquired Urinary Tract Infection Testing Market Share Forecast by Type (2023-2028)
Figure 37. Global Hospital-acquired Urinary Tract Infection Testing Revenue Share by Application in 2021
Figure 38. Global Hospital-acquired Urinary Tract Infection Testing Market Share Forecast by Application (2023-2028)
Figure 39. North America Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Type (2017-2028)
Figure 40. North America Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Application (2017-2028)
Figure 41. North America Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Country (2017-2028)
Figure 42. United States Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Type (2017-2028)
Figure 46. Europe Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Application (2017-2028)
Figure 47. Europe Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Country (2017-2028)
Figure 48. Germany Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Region (2017-2028)
Figure 56. China Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Type (2017-2028)
Figure 63. South America Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Application (2017-2028)
Figure 64. South America Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Hospital-acquired Urinary Tract Infection Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock